Therefore, the present study was undertaken to investigate PEMT transcriptional regulation from genetic (BRCA1 mutation or not) and epigenetic (promoter methylation and histone modifications) aspects, and to provide novel insight into epigenetic change-mediated abnormal PEMT expression in BRCA1-mutated breast cancer progression. The gene discussed is BRCA1; the disease is breast cancer.